Friday May 10
Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories
With its CLIA certification, Parkway helped Rosetta Genomics to obtain CLIA certification for its laboratory in Philadelphia.
Rosetta Genomics Rating Lowered to Neutral at Sidoti
Rosetta Genomics traded down 4.58% on Friday, hitting $3.9599. Rosetta Genomics has a 52-week low of $1.40 and a 52-week high of $23.43. The stock's 50-day moving average is currently $4.46. The company's market cap is $36.0 million.